| abstract |
The present invention relates to the field of immunological diseases and hyperproliferative diseases. More particularly, the present invention relates to therapeutic antibody: antigen complexes, soluble antigens and methods for detecting and monitoring soluble antigen: antigen complexes, wherein the patient has undergone at least one course of immunotherapy. Yes. Still further, therapeutic antibody: antigen complex levels, soluble antigen levels or soluble therapeutic antibody levels can be measured and used to stage and monitor hyperproliferative disorders. |